Literature DB >> 21548611

Comparative triplex tandem mass spectrometry assays of lysosomal enzyme activities in dried blood spots using fast liquid chromatography: application to newborn screening of Pompe, Fabry, and Hurler diseases.

Zdeněk Spáčil1, Susan Elliott, Steven L Reeber, Michael H Gelb, C Ronald Scott, František Tureček.   

Abstract

We report a comparative study of triplex tandem mass spectrometry (MS/MS) based assays of lysosomal enzymes in dried blood spots for the early detection of Pompe, Fabry, and Hurler diseases in newborns. Four methods have been evaluated that differed in sample handling and the equipment used. A newly developed method uses assay quenching with acetonitrile to precipitate blood proteins followed by analysis on an LC-electrospray/MS/MS system capable of multiple consecutive sample injections on two parallel chromatographic columns. This method requires 1.5 min per a triplex analysis of enzyme products and internal standards, which matches the throughput of the previously reported flow injection method. LC separation reduces matrix effects and allows for more facile sample workup. The new LC-based method showed figures of merit that were superior to those of the currently used method based on liquid-liquid extraction into ethyl acetate and flow injection into the mass spectrometer. The other methods we investigated for comprehensive comparison involved liquid-liquid extraction into ethyl acetate followed by LC-ESI-MS/MS and acetonitrile quenching followed by direct flow injection. Both methods using acetonitrile quenching were found to be robust and provide good quality data while requiring fewer liquid transfer steps and less disposable material and labor than did the extraction methods. The individual merits of the new methods are discussed to present an evaluated alternative approach to high-throughput analysis in newborn screening laboratories.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21548611      PMCID: PMC3115456          DOI: 10.1021/ac200417u

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  28 in total

1.  Diagnosis of alpha-L-iduronidase deficiency in dried blood spots on filter paper: the possibility of newborn diagnosis.

Authors:  N A Chamoles; M Blanco; D Gaggioli
Journal:  Clin Chem       Date:  2001-04       Impact factor: 8.327

2.  Hurler-like phenotype: enzymatic diagnosis in dried blood spots on filter paper.

Authors:  N A Chamoles; M B Blanco; D Gaggioli; C Casentini
Journal:  Clin Chem       Date:  2001-12       Impact factor: 8.327

3.  Fabry disease: enzymatic diagnosis in dried blood spots on filter paper.

Authors:  N A Chamoles; M Blanco; D Gaggioli
Journal:  Clin Chim Acta       Date:  2001-06       Impact factor: 3.786

4.  Automated affinity capture-release of biotin-containing conjugates using a lab-on-valve apparatus coupled to UV/visible and electrospray ionization mass spectrometry.

Authors:  Yuko Ogata; Louis Scampavia; Jaromír Růzicka; C Ronald Scott; Michael H Gelb; Frantisek Turecek
Journal:  Anal Chem       Date:  2002-09-15       Impact factor: 6.986

5.  Tandem mass spectrometry for the direct assay of lysosomal enzymes in dried blood spots: application to screening newborns for mucopolysaccharidosis II (Hunter Syndrome).

Authors:  Brian J Wolfe; Sophie Blanchard; Martin Sadilek; C Ronald Scott; Frantisek Turecek; Michael H Gelb
Journal:  Anal Chem       Date:  2010-12-30       Impact factor: 6.986

6.  Newborn screening for Fabry disease by measuring GLA activity using tandem mass spectrometry.

Authors:  Angéla Dajnoki; György Fekete; Joan Keutzer; Joseph J Orsini; Victor R De Jesus; Yin-Hsiu Chien; Wuh-Liang Hwu; Zoltan Lukacs; Adolf Mühl; X Kate Zhang; Olaf Bodamer
Journal:  Clin Chim Acta       Date:  2010-03-22       Impact factor: 3.786

7.  The effects of sample preparation methods on the variability of the electrospray ionization response for model drug compounds.

Authors: 
Journal:  Rapid Commun Mass Spectrom       Date:  1999-06       Impact factor: 2.419

8.  Tandem mass spectrometry for the direct assay of lysosomal enzymes in dried blood spots: application to screening newborns for mucopolysaccharidosis VI (Maroteaux-Lamy syndrome).

Authors:  Trisha A Duffey; Martin Sadilek; C Ronald Scott; Frantisek Turecek; Michael H Gelb
Journal:  Anal Chem       Date:  2010-10-20       Impact factor: 6.986

9.  Development and evaluation of quality control dried blood spot materials in newborn screening for lysosomal storage disorders.

Authors:  Victor R De Jesus; X Kate Zhang; Joan Keutzer; Olaf A Bodamer; Adolf Mühl; Joseph J Orsini; Michele Caggana; Robert F Vogt; W Harry Hannon
Journal:  Clin Chem       Date:  2008-11-06       Impact factor: 8.327

10.  Tandem mass spectrometry for the direct assay of lysosomal enzymes in dried blood spots: application to screening newborns for mucopolysaccharidosis I.

Authors:  Sophie Blanchard; Martin Sadilek; C Ronald Scott; Frantisek Turecek; Michael H Gelb
Journal:  Clin Chem       Date:  2008-12       Impact factor: 8.327

View more
  15 in total

1.  New substrates and enzyme assays for the detection of mucopolysaccharidosis III (Sanfilippo Syndrome) types A, B, C, and D by tandem mass spectrometry.

Authors:  Brian J Wolfe; Farideh Ghomashchi; Tim Kim; Cynthia A Abam; Martin Sadilek; Rhona Jack; Jerry N Thompson; C Ronald Scott; Michael H Gelb; Frantisek Turecek
Journal:  Bioconjug Chem       Date:  2012-03-09       Impact factor: 4.774

2.  Protonation sites and dissociation mechanisms of t-butylcarbamates in tandem mass spectrometric assays for newborn screening.

Authors:  Zdeněk Spáčil; Renjie Hui; Michael H Gelb; František Tureček
Journal:  J Mass Spectrom       Date:  2011-10       Impact factor: 1.982

Review 3.  Newborn Screening for Lysosomal Storage Disorders.

Authors:  Roy W A Peake; Olaf A Bodamer
Journal:  J Pediatr Genet       Date:  2016-12-02

4.  Multiplex Tandem Mass Spectrometry Enzymatic Activity Assay for Newborn Screening of the Mucopolysaccharidoses and Type 2 Neuronal Ceroid Lipofuscinosis.

Authors:  Yang Liu; Fan Yi; Arun Babu Kumar; Naveen Kumar Chennamaneni; Xinying Hong; C Ronald Scott; Michael H Gelb; Frantisek Turecek
Journal:  Clin Chem       Date:  2017-04-20       Impact factor: 8.327

Review 5.  Newborn screening for lysosomal storage disorders and other neuronopathic conditions.

Authors:  Dietrich Matern; Devin Oglesbee; Silvia Tortorelli
Journal:  Dev Disabil Res Rev       Date:  2013

Review 6.  Lysosomal diseases: diagnostic update.

Authors:  Bryan Winchester
Journal:  J Inherit Metab Dis       Date:  2014-04-08       Impact factor: 4.982

Review 7.  Contribution of tandem mass spectrometry to the diagnosis of lysosomal storage disorders.

Authors:  Monique Piraud; Magali Pettazzoni; Pamela Lavoie; Séverine Ruet; Cécile Pagan; David Cheillan; Philippe Latour; Christine Vianey-Saban; Christiane Auray-Blais; Roseline Froissart
Journal:  J Inherit Metab Dis       Date:  2018-03-19       Impact factor: 4.982

8.  High-throughput assay of 9 lysosomal enzymes for newborn screening.

Authors:  Zdenek Spacil; Haribabu Tatipaka; Mariana Barcenas; C Ronald Scott; Frantisek Turecek; Michael H Gelb
Journal:  Clin Chem       Date:  2013-01-11       Impact factor: 8.327

Review 9.  Pompe disease: literature review and case series.

Authors:  Majed Dasouki; Omar Jawdat; Osama Almadhoun; Mamatha Pasnoor; April L McVey; Ahmad Abuzinadah; Laura Herbelin; Richard J Barohn; Mazen M Dimachkie
Journal:  Neurol Clin       Date:  2014-08       Impact factor: 3.806

10.  Identification of infants at risk for developing Fabry, Pompe, or mucopolysaccharidosis-I from newborn blood spots by tandem mass spectrometry.

Authors:  C Ronald Scott; Susan Elliott; Norman Buroker; Lauren I Thomas; Joan Keutzer; Michael Glass; Michael H Gelb; Frantisek Turecek
Journal:  J Pediatr       Date:  2013-03-01       Impact factor: 4.406

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.